Lv5
916 积分 2022-02-22 加入
Case Report: CAR‐T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation
3天前
已完结
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects
9天前
已完结
Ponatinib-Associated Cutaneous Eruptions—A Case Series and Review of Clinicopathologic Findings
1个月前
已完结
Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinases
2个月前
已完结
Favorable Rates of Cardiovascular Events with Stringent Cardiovascular Monitoring and a Lowered Dose of Ponatinib as Second-Line Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Failing or Intolerant to First-Line Second-Generation Tyrosine Kinase Inhibitor Treatment: Results of the Prospective PONS Trial
2个月前
已关闭
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
2个月前
已完结
How I Treat Advanced Phases of CML
2个月前
已完结
Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
2个月前
已完结
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
3个月前
已完结
Chronic myeloid leukaemia
3个月前
已完结
皖公网安备34019202002308
